Stryker (SYK) Q1 2024 Earnings
SYK·Reported April 30, 2024·After market close
Stryker reported Q1 2024 revenue of $5.2B, beat analyst consensus of $5.1B by $138.5M. Diluted EPS came in at $2.50, beat the $2.35 consensus by $0.15. Stryker reports across 2 business segments, led by MedSurg and Neurotechnology and Orthopaedics.
Revenue
$5.2Bbeat by $138.5M
Consensus: $5.1BDiluted EPS
$2.50beat by $0.15
Consensus: $2.35
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Stryker's Q1 2024 earnings report.
Stryker (SYK) reported Q1 2024 earnings on April 30, 2024 after market close.
Stryker reported revenue of $5.2B and diluted EPS of $2.50 for Q1 2024.
Revenue beat the consensus estimate of $5.1B by $138.5M. EPS beat the consensus estimate of $2.35 by $0.15.
You can read the 10-Q periodic report (0000310764-24-000064) directly on SEC EDGAR. The filing index links above go to sec.gov.